MARKET

ABSI

ABSI

Absci Corp
NASDAQ
3.130
-0.090
-2.80%
After Hours: 3.130 0 0.00% 19:57 04/25 EDT
OPEN
3.220
PREV CLOSE
3.220
HIGH
3.240
LOW
3.120
VOLUME
1.58M
TURNOVER
--
52 WEEK HIGH
6.33
52 WEEK LOW
2.010
MARKET CAP
398.62M
P/E (TTM)
-3.3465
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ABSI last week (0414-0418)?
Weekly Report · 5d ago
Absci Is Maintained at Overweight by Keybanc
Dow Jones · 04/16 12:30
Keybanc Maintains Overweight on Absci, Raises Price Target to $9
Benzinga · 04/16 12:20
Absci price target raised to $9 from $5 at KeyBanc
TipRanks · 04/16 10:50
KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)
TipRanks · 04/16 07:36
Absci: FDA Announcement Provides Only A Modest Tailwind
Seeking Alpha · 04/14 15:40
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
Barchart · 04/14 15:05
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
Benzinga · 04/14 09:14
More
About ABSI
More
Absci Corporation is a data-first generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. The Company’s Integrated Drug Creation platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, its Integrated Drug Creation platform aims to engineer biologics. It is developing a diversified portfolio of programs with a focus on cytokine biology. It has three wholly owned internal pipeline programs focusing on cytokine biology, as well as several other undisclosed pipeline programs under evaluation. Its wholly owned pipeline programs include ABS-101, ABS-201, and ABS-301. The Company’s other pipeline programs include ABS-501 and additional drug creation programs.
Recently
Symbol
Price
%Change

Webull offers Absci Corp stock information, including NASDAQ: ABSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABSI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABSI stock methods without spending real money on the virtual paper trading platform.